Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-354-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
No data is available on the toxicokinetics, metabolism and distribution of β-Alanine, N-(2-carboxyethyl)-N-[3-[(2-carboxyethyl)amino]propyl]-, N-C12-18-alkyl derivs., trisodium salt. Based on the toxicological profile of the substance this information is not considered as a requirement. The information in this chapter has therefore been derived based on the physicochemical properties of the substance.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 50
- Absorption rate - inhalation (%):
- 100
Additional information
Structurally, the substances within the amphoteric, proprionates such as β-Alanine, N-(2-carboxyethyl)-N-[3-[(2-carboxyethyl)amino]propyl]-, N-C12-18-alkyl derivs., trisodium salt have a linear alkyl chain and one carboxymethylated nitrogen at the end, with in this case 2 carboxyethylated amines in between. Under physiological conditions all nitrogens are positively charged as they are proton acceptors. The carboxylic groups acts as proton donors and are protonated only at lower pH. This results in different overall charge of the molecule depending on the pH; at lower pH the net charge is positive and at neutral or higher pH the overall charge is negative. This gives a structure consisting of a charged part with the carboxyethylated nitrogens and an apolar tail. The apolar carbon chain could easily dissolve in membranes, whereas the polar head would stay in the outside. As a consequence, the whole molecule will not easily pass membrane structures.
β-Alanine, N-(2-carboxyethyl)-N-[3-[(2-carboxyethyl)amino]propyl]-, N-C12-18-alkyl derivs., trisodium salt has a molecular weight of 524 g/Mol and a log Kow of -2.74. It is very water soluble manufactured and sold as a ca. 30% solution in water with a low vapour pressure of 1.5 mPa at 20°C. The non-toxicological profile of the substance results in that is does not have to be classified nor labeled according to the Regulation (EC) No 1272/2008 on classification, labeling and packaging of substances and mixtures.
Absorption via oral route is considered to be complete and by dermal route low, based on the substance being a salt which easily dissociates in water. As a worst case, absorption via the inhalational route is also considered to be complete, although exposure to the substance via inhalation is very unlikely based on the physical appearance of the substance. The substance is not considered to have a potential for bioaccumulation, based on its hign water solubility properties and the low Kow value.
Oral absorption
No actual data on the toxicokinetic properties of the amphoteric, proprionates in particular for β-Alanine, N-(2-carboxyethyl)-N-[3-[(2-carboxyethyl)amino]propyl]-, N-C12-18-alkyl derivs., trisodium salt are available. Due to no actual oral absorption data on any of the substances within the group, the default 50% is used in the risk assessment.
Absorption of inhaled compound
The substances are manufactured, marketed and handled as aqueous solutions. Together with the relatively low vapour pressure, inhalational exposure is considered to be very limited. As a worst case, absorption via the inhalational route is considered to be 100%, although exposure to the substance via inhalation is unlikely based on the physical appearance of the substance.
Dermal absorption
The partition coefficient (Log Kow) at 2/.74 indicates that the substance is not sufficiently lipophilic to cross the stratum corneum. This is further supported by the fact that the water solubility is high for this substance. All this taken together and in combination with the high molecular weight, the dermal absorption is considered to be low. But due to no relevant data on the substance, the default 50% is used in the risk assessment.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.